Cancer clinical trials in the region Pays de la Loire
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Lymphoma
#NCT06006117
B cell lymphoma
Marginal zone lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Antoine Lacassagne (Nice), CHU Nice Hôpital l'Archet (Nice) (and 18 more...)
Organisation de recherche universitaire sur le lymphome
Phase 3
Lung cancer
#NCT05920356
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
PDL1 Negative (< 1%)
Targeted therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Hospitalier de Cornouaille (Quimper), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Nîmes (Nîmes), Institut Curie - Paris (Paris), CHU de Rennes - Hôpital Pontchaillou (Rennes) (and 18 more...)
Amgen
Phase 3
Lung cancer
#NCT05668988
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nantes (Nantes), Hôpital d'instruction des Armées Bégin (Saint-Mandé), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Centre Hospitalier Universitaire de Grenoble (La Tronche) (and 7 more...)
Debiopharm International SA
Phase 3
Breast cancer
#NCT05296798
HER2 Positive
HR Positive
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre Hospitalier Universitaire de Grenoble (La Tronche) (and 4 more...)
Hoffmann-La Roche
Phase 3
Lung cancer
#NCT05555732
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Negative (< 1%)
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
EGFR
BRAF
MET
ALK
RET
ROS-1
NTRK-1/2/3
Other mutation
Immunotherapy
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Immunotherapy
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Léon Bérard (Lyon), Hôpital Foch (Suresnes) (and 5 more...)
Daiichi Sankyo
Phase 3
Breast cancer
#NCT05514054
HER2 Negative
HR Positive
Localized
Hormone therapy
Institut Bergonié (Bordeaux), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique de Blois (La Chaussée-Saint-Victor), Groupe Hospitalier La Rochelle-Ré-Aunis (La Rochelle), Clinique Chénieux (Limoges) (and 31 more...)
Eli Lilly et compagnie
Phase 3
Lymphoma
#NCT05508867
Hodgkin lymphoma
None
Immunotherapy
1
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
Centre Hospitalier Universitaire Dupuytren (Limoges), Hôpital Henri-Mondor AP-HP (Créteil), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes)
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT04790253
SCLC (Small Cell Lung Cancer)
Chemotherapy
Chemotherapy
Centre Henri Becquerel (Rouen ), Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 7 more...)
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 3
Lung cancer
#NCT06151574
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
HER2
Systemic Treatment-Naive
CHU de Rennes - Hôpital Pontchaillou (Rennes), Hôpital Tenon AP-HP (Paris ), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Centre Léon Bérard (Lyon) (and 1 more...)
Boehringer Ingelheim
Phase 3
Breast cancer
#NCT05382286
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
Immunotherapy
Immunotherapy
Bispecific T-cell engager antibodies
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre François Baclesse (Caen ), Centre Jean Perrin (Clermont Ferrand ) (and 9 more...)
Gilead Sciences